607 related articles for article (PubMed ID: 22124143)
1. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.
Seki E; Schnabl B
J Physiol; 2012 Feb; 590(3):447-58. PubMed ID: 22124143
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling and liver fibrosis.
Aoyama T; Paik YH; Seki E
Gastroenterol Res Pract; 2010; 2010():. PubMed ID: 20706677
[TBL] [Abstract][Full Text] [Related]
3. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.
Frasinariu OE; Ceccarelli S; Alisi A; Moraru E; Nobili V
Dig Liver Dis; 2013 Jul; 45(7):543-51. PubMed ID: 23280158
[TBL] [Abstract][Full Text] [Related]
4. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
Nagata K; Suzuki H; Sakaguchi S
J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
[TBL] [Abstract][Full Text] [Related]
5. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.
Seo YS; Shah VH
Clin Mol Hepatol; 2012 Dec; 18(4):337-46. PubMed ID: 23323248
[TBL] [Abstract][Full Text] [Related]
6. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.
Chen D; Le TH; Shahidipour H; Read SA; Ahlenstiel G
Cells; 2019 Oct; 8(11):. PubMed ID: 31717860
[TBL] [Abstract][Full Text] [Related]
7. Role of toll-like receptors in immune activation and tolerance in the liver.
Nakamoto N; Kanai T
Front Immunol; 2014; 5():221. PubMed ID: 24904576
[TBL] [Abstract][Full Text] [Related]
8. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors in acute liver injury and regeneration.
Chen Y; Sun R
Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
Kawaratani H; Moriya K; Namisaki T; Uejima M; Kitade M; Takeda K; Okura Y; Kaji K; Takaya H; Nishimura N; Sato S; Sawada Y; Seki K; Kubo T; Mitoro A; Yamao J; Yoshiji H
Int J Mol Med; 2017 Aug; 40(2):263-270. PubMed ID: 28627645
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
Roh YS; Seki E
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):38-42. PubMed ID: 23855294
[TBL] [Abstract][Full Text] [Related]
12. Role of Toll-like receptors in liver health and disease.
Broering R; Lu M; Schlaak JF
Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.
Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(44):16443-51. PubMed ID: 25469012
[TBL] [Abstract][Full Text] [Related]
14. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?
Bode C; Bode JC
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):166S-71S. PubMed ID: 16344604
[TBL] [Abstract][Full Text] [Related]
15. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
[TBL] [Abstract][Full Text] [Related]
16. The unfolding web of innate immune dysregulation in alcoholic liver injury.
Szabo G; Mandrekar P; Petrasek J; Catalano D
Alcohol Clin Exp Res; 2011 May; 35(5):782-6. PubMed ID: 21284666
[TBL] [Abstract][Full Text] [Related]
17. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
[TBL] [Abstract][Full Text] [Related]
18. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
19. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
20. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
